top of page
Strategic Solutions to Commercial Complexity
Theranostic & Radioligand Strategies LLC was founded in 2011 by Andrew Beck, BS, MBA, CNMT, a senior executive with nearly 40 years of experience in the radiopharmaceutical industry
About Andrew Beck
Andrew's career spans leadership roles across some of the most recognized organizations in the field, including Cardinal Health, Lantheus, Progenics Pharmaceuticals, Syncor International, and Lehigh Valley Health Network.
His experience provides a uniquely comprehensive perspective - from direct patient care to senior executive-level strategy and product launch execution.
This breadth enables a level of insight that integrates clinical realities, operational constraints, and commercial strategy - an essential combination for radiopharmaceutical success.
Theranostic & Radioligand Strategies exists to help companies and investors navigate complexity, reduce risk, and build credible paths to commercial success.
Work with an advisor who has operated at every level of the radiopharmaceutical ecosystem
Schedule a confidential discussion.
bottom of page